Supernus Pharmaceuticals | SUPN - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.94B 642M 2026-06
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eisai JPY 52.02B 931M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Novo Nordisk DKK 13.6B 1.55B 2026-03
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 643.7M 103.7M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03